Comment on serum FGF21 and RBP4 levels in patients with chronic hepatitis C

Motoh IwasaDepartment of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, JapanCorrespondence[email protected]

Rumi Mifuji-MorokaDepartment of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan

Yoshinao KobayashiDepartment of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan

Yoshiyuki TakeiDepartment of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan

Corina D' Alessandro-GabazzaDepartment of Immunology, Mie University Graduate School of Medicine, Tsu, Japan

Esteban C GabazzaDepartment of Immunology, Mie University Graduate School of Medicine, Tsu, Japan

References

Kukla M, Berdowska A, Stygar D, Gabriel A, Mazur W, Logiewa-Bazger B, Serum FGF21 and RBP4 levels in patients with chronic hepatitis C. Scand J Gastroenterol 2012: in press.
PubMedGoogle Scholar
Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf) 2009;71:369–75.
PubMed Web of Science ®Google Scholar
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010;139:456–63.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Comment on serum FGF21 and RBP4 levels in patients with chronic hepatitis C

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comment on serum FGF21 and RBP4 levels in patients with chronic hepatitis C

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date